chartexchange

GLAXF
GSK PLC
stockOTC

EODNov 18, 2026
24.45USD+0.088%(+0.02)119
Loading…
Loading…
101.28B
Healthcare
Drug Manufacturers-General
HQ
Brentford, Middlesex, United Kingdom
69,400
Previous Close
$25.45
Beta
0.22
52-Week High
$31.48 2026-02-18
52-Week Low
$22.46 2025-11-18
SMA 50
$24.93
SMA 200
$24.55
Avg. Vol 10D
7,085
Avg. Vol 30D
3,801
Avg. Vol 90D
2,141
Relative Vol
0.34
3.89B
Jul 19, 2022 · 4-for-5 (reverse)
GLAXF Profile

we are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. as one of the few healthcare companies researching both medicines and vaccines for the world health organization's three priority diseases – hiv/aids, tuberculosis and malaria, we are very proud to have developed some of the leading global medicines in these fields. our product portfolio also includes a range of consumer brands, many of which are household names around the world, including sensodyne, aquafresh, horlicks, panadol and tums.

GLAXF Performance
PeriodPriceDateChangeBeta
1W25.232026-11-11-3.16%-5.442
1M24.742026-10-19-1.24%-0.176
3M25.352026-08-17-3.62%-0.105
6M26.002026-05-21-6.03%-0.059
1Y22.462025-11-18+8.77%0.221
2Y16.862024-11-18+44.89%—
5Y25.002021-11-18-2.27%0.217
GLAXF Stock Summary

GSK PLC (OTC:GLAXF) stock price today is $24.43, and today's volume is 1,284. GLAXF is down 4.002% today. The 30 day average volume is 3,801. GLAXF market cap is $101.28B with 4.15B shares outstanding.